Geode Capital Management LLC Acquires 31,956 Shares of NanoViricides, Inc. (NYSE:NNVC)

Geode Capital Management LLC boosted its holdings in shares of NanoViricides, Inc. (NYSE:NNVC) by 28.7% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 143,313 shares of the company’s stock after purchasing an additional 31,956 shares during the period. Geode Capital Management LLC owned about 1.03% of NanoViricides worth $205,000 at the end of the most recent reporting period.

Separately, Virtu Financial LLC purchased a new position in shares of NanoViricides during the fourth quarter valued at approximately $91,000. 10.30% of the stock is owned by hedge funds and other institutional investors.

NanoViricides Stock Down 2.3 %

Shares of NanoViricides stock opened at $1.30 on Friday. The business has a 50 day moving average of $1.25 and a 200 day moving average of $1.33. NanoViricides, Inc. has a 52 week low of $0.94 and a 52 week high of $3.59. The company has a market cap of $20.33 million, a PE ratio of -1.81 and a beta of 0.93.

NanoViricides Company Profile

NanoViricides, Inc, a clinical stage nano-biopharmaceutical company, discovers, develops, and commercializes drugs for the treatment of viral infections. The company's product portfolio includes NV-CoV-2, nanoviricide drug which is in phase 1a/1b clinical trails for the treatment of Covid; and NV-CoV-2 Oral Syrup, and NV-CoV-2 Oral Gummies, a semi-solid fixed-dose form which are in phase 1a/1b human clinical trials for enabling body-weight-based dose titration as is required for pediatric cases.